BCJ Capital Management »

Neurocrine Biosciences shares owned by BCJ Capital Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by BCJ Capital Management from 13F filings

Historical chart of BCJ Capital Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by BCJ Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by BCJ Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $230k 1.7k 137.67
2024-03-31 $284k 2.1k 137.92

More positions owned by BCJ Capital Management

Select Sector Spdr Tr Technology (XLK)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Ishares Tr Core Total Usd (IUSB)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr Core S&p Us Vlu (IUSV)
Select Sector Spdr Tr Indl (XLI)

View all positions for BCJ Capital Management

Top funds holding Neurocrine Biosciences

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Bellevue Group
Geode Capital Management
Citadel Advisors
AQR Capital Management
T. Rowe Price Associates
Morgan Stanley
Jpmorgan Chase & Co
Deerfield Management Company
Dodge & Cox
Goldman Sachs Group

View all funds holding Neurocrine Biosciences